Baird Medical Investment Holdings Ltd（BDMD）のニュースとイベントBDMDBaird Medical Investment Holdings Ltd

Baird Medical Monitors Ordinary Share Price Volatility

Baird Medical has provided the following statement regarding recent volatility in the market price of its ordinary shares: "The Company is closely monitoring these fluctuations in the market price of its ordinary shares and the associated trading activity, and is not currently aware of any material development or otherwise undisclosed reason that would explain the recent decline in its ordinary share price. Baird Medical management believes that the Company's current market valuation does not accurately reflect the strength of its underlying business fundamentals, capabilities, and growth potential. The Company remains committed to the execution of its growth strategy, and to preserving shareholder value."

Baird Medical Enters Exclusive Distribution Agreement with China Resources Medical Devices

Baird Medical announced that its subsidiary in the People's Republic of China, Nanjing Changcheng Medical Equipment Company Limited, has entered into a distribution agreement with China Resources Pharmaceutical Commercial Group Medical Devices, a subsidiary of China Resources Pharmaceutical Group. Under the agreement, China Resources Medical Devices will serve as the exclusive distributor for Baird's specified microwave ablation products in 19 key markets in the People's Republic of China, with a focus on regions where Baird has historically had a limited direct commercial presence. On execution of the agreement, China Resources Medical Devices placed an initial order totaling about RMB 6M, or $900,000. "This partnership with China Resources Medical Devices, one of the leading medical technology distributors in the PRC, provides another important validation of our technology. It will further strengthen our leadership position in China and help accelerate access to hospitals in previously untapped regions. With their extensive distribution network and nationwide prominence, we believe that adding our products to China Resources' portfolio could help drive further adoption of our MWA technology throughout the country. We remain committed to growing our business in the Chinese market, and expect that this agreement will play an important role in achieving this goal while we continue to expand in other key global markets, including the U.S.," said Haimei Wu, chairwoman and CEO of Baird Medical.

Baird Medical Announces Additional Medical Device Registrations in Vietnam

Baird Medical Investment Holdings announced additional medical device registrations in Vietnam. Baird Medical received Class C medical device registration certificates for several products within its microwave ablation portfolio, including its J-series microwave ablation needles for benign thyroid nodules, G-series needles for liver tumors, and MTI-5AT and MTI-5ET microwave ablation generators.